CICigna Group

NYSE cigna.com


$ 332.86 $ 4.62 (1.41 %)    

Tuesday, 13-Aug-2024 15:59:58 EDT
QQQ $ 462.33 $ 11.20 (2.48 %)
DIA $ 397.90 $ 4.02 (1.02 %)
SPY $ 542.04 $ 8.77 (1.64 %)
TLT $ 97.28 $ 0.67 (0.69 %)
GLD $ 228.03 $ -0.35 (-0.15 %)
$ 332.72
$ 332.47 x 200
-- x --
-- - --
$ 251.86 - $ 364.21
1,057,580
na
93.01B
$ 0.90
$ 25.08
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stephens--co-reiterates-overweight-on-cigna-group-maintains-410-price-target

Stephens & Co. analyst Scott Fidel reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $410 price target.

 barclays-maintains-overweight-on-cigna-group-raises-price-target-to-405

Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $393 to $405.

 us-stocks-tumble-on-economic-geopolitical-concerns-small-caps-chipmakers-sink-meta-rallies-whats-driving-markets-thursday

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...

 cignas-q2-profit-beats-analyst-estimates-as-evernorth-health-services-growth-builds-momentum-reiterates-annual-outlook

Cigna reported Q2 sales of $60.52 billion, up 25% YoY, beating estimates. Growth was driven by Evernorth Health Services' c...

 wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-data-stock-performances-suggest-republican-win-in-november

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...

 apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

 bofa-downgrades-elevance-health-on-medicaid-pressure-and-lowered-peer-valuations

Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid me...

 healthcare-investors-bet-on-easier-medicare-rules-under-potential-trump-administration

Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks ...

 is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions-in-the-us

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on d...

Core News & Articles

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...

 cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION